MSN customer base exceeds two hundred fifty (250) with a global presence in sixty-five (65) countries throughout North America, Europe, Latin America, Middle East, the Pacific Rim, and Africa. All of the major U.S generic pharmaceutical companies are currently sourcing MSN’s finished APIs. With more than 350 National & International patents filed, our portfolio offers over three hundred (300) APIs & two hundred (200) product formulations in multiple therapeutic categories.
Established in 2014, MSN Pharmaceuticals Inc., (MSN PI) is a state-of-the-art finished dosage manufacturing facility based out of Piscataway, New Jersey. MSN PI is a fully owned subsidiary of the MSN group of companies and is specialized in contract development and manufacturing of high-quality generic pharmaceutical products. MSN PI offers Contract Development and Manufacturing services of complex pharmaceutical products with backward integrated APIs to global markets.